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Introduction: Lactate is a marker of hypoperfusion and may be used for risk assessment in critically ill patients.
Although evidence suggests that repeated lactate measurements are of clinical interest, how and when lactate
should be analyzed is controversial. Intravascular microdialysis provides a novel method for the continuous
monitoring of lactate, which may be clinically beneficial in critically ill patients.
Methods: Circulating lactate levels were continuously monitored in 80 patients undergoing cardiac surgery using
either a separate single-lumen microdialysis catheter or a triple-lumen central venous catheter with an integrated
microdialysis function. The catheter was placed with the tip positioned in the superior vena cava. Arterial blood gas
samples were taken every hour to obtain reference values, and the lactate levels were analyzed in a blood gas
analyzer.
Results: A total of 1,601 paired microdialysis–arterial blood gas lactate samples were obtained. Bland-Altman analysis
showed a bias (mean difference) ± limits of agreement (±1.96 SD) of 0.02 ± 0.42 mmol/L. The regression coefficient was
0.98 (P = 0.0001).
Conclusions: Central venous microdialysis is an accurate and reliable method for continuous blood lactate
monitoring in patients undergoing cardiac surgery. The system may be useful for early lactate-guided therapy in
critically ill patients.Introduction
Blood lactate level is a clinically important biomarker in
critically ill patients, and its measurement may aid in
monitoring of hemodynamics [1]. Elevated blood lactate
is strongly associated with adverse outcomes in critically
ill patients and thus has prognostic value [2-4]. Hyper-
lactatemia has traditionally been considered to be a sign
of tissue hypoperfusion due to anaerobic metabolism [5],
such as during cardiogenic shock. Investigators in recent
studies have suggested that elevated blood lactate during
critical disease is the result of not only tissue hypoperfu-
sion but also adrenergic stress [6]. This phenomenon* Correspondence: fanny.schierenbeck@ki.se
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article, unless otherwise stated.was demonstrated for skeletal muscle, where epineph-
rine activates the Na+/K+-ATPase pump independently
of tissue hypoxia [7]. An elevated blood lactate concen-
tration may result from both increased production and
decreased clearance. Lactate clearance occurs mainly in
the liver and is dependent on tissue perfusion. In addition
to elevations in lactate, the rate of normalization of ele-
vated lactate levels is also independently associated with
increased mortality [8,9].
Lactate monitoring may thus be used for risk stratifi-
cation in critically ill patients [10,11] and for early
lactate-guided treatment. Researchers in a prospective
randomized trial showed that lactate-guided treatment
in patients with hyperlactatemia resulted in improved
outcomes [12]. Cardiac surgery patients often develop
hyperlactatemia postoperatively [13], which may be af-
fected by several factors, such as the type of surgery,entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Elevated lactate levels in this patient category are also
associated with postoperative mortality and a prolonged
ICU stay [14,15]. A similar relation was observed for
pediatric cardiac surgery patients [16].
We have previously evaluated intravascular microdialysis
to monitor glucose, both offline and continuously [17-19].
In our first study, we compared intravascular microdialysis
lactate values offline with arterial blood lactate concentra-
tion [17], but we did not study the online continuous mon-
itoring of lactate. The aim of our present observational
study was to evaluate intravascular microdialysis as a
method for continuous lactate monitoring in cardiac sur-
gery patients by comparing the accuracy of microdialysis
lactate values with reference values analyzed by an arterial
blood gas test. In addition, we recorded major postopera-
tive complications in relation to lactate levels.
Methods
Ethical approval
The study was approved by the Stockholm Regional
Ethical Review Board. Before their inclusion in the
study, patients gave their written consent to participate.
Patients
The study included 80 randomly selected patients who
underwent routine elective cardiac cardiopulmonary by-
pass surgery at the Karolinska University Hospital in
Stockholm during two time periods: between March and
July 2010 (n = 50 patients monitored with a single-lumen
catheter (SLC)) and between May and August 2011
(n = 30 patients monitored with a triple-lumen cath-
eter (TLC)). The study groups were separated in time
because different microdialysis catheters were used
(see patient monitoring). However, the microdialysis equip-
ment used was the same in both groups (microdialysis-
membrane, sensor and monitor system). We previously
evaluated intravascular microdialysis for continuous glu-
cose monitoring in patients monitored with the SLC
[18] and patients monitored with the TLC [19].
Patient monitoring
Blood lactate was continuously monitored in all patients
using the Eirus intravascular microdialysis system (Maquet
Critical Care, Solna, Sweden), which measures small me-
tabolites such as glucose and lactate without blood sam-
pling. The first group of patients (n = 50) had a separate
single-lumen microdialysis catheter for microdialysis (Eirus
SLC; Maquet Critical Care), and the second group of pa-
tients (n = 30) had a TLC (Eirus TLC; Maquet Critical
Care) functioning as a regular central venous catheter
(CVC) with an integrated microdialysis function. The pa-
tients monitored with a SLC had an additional CVC for
sufficient central venous access. Both the SLC and the TLCwere connected to a sensor that continuously analyzes glu-
cose and lactate values and displays them on a screen. A
schematic illustration of the microdialysis system is pro-
vided in Figure 1. All the patients had the microdialysis
catheter placed preoperatively after being put under gen-
eral anesthesia. The catheter was inserted into the internal
jugular vein as a regular CVC. The length of the SLC is
30 cm, and the length of the TLC is 16 cm. Both catheters
were positioned with placement of the microdialysis mem-
brane in the superior vena cava/right atrium. Thus the
TLC was inserted for its whole length, whereas the SLC
was inserted according to length markers on the catheter.
The microdialysis catheter was then connected to the sen-
sor, and the perfusion of the system was started with 0.9%
sodium chloride. The perfusion of the system takes ap-
proximately 5 minutes, implying a time lag between the ac-
tual lactate levels present near the microdialysis membrane
and the levels measured ex vivo in the dialysis fluid. The
Eirus system recorded and displayed the lactate values.
In addition to enabling the microdialysis system, the
TLC was used for both drug administration and blood
sampling and was removed when a central line was no
longer necessary. The SLC was removed when the con-
tinuous lactate monitoring was ended. After removal,
the microdialysis membrane was checked for potential
blood clotting. The patients were given standard anti-
thrombotic prophylaxis with low-molecular-weight hep-
arin (LMWH) 24 hours after surgery. Patients with an
indication for warfarin were started on LMWH until a
therapeutic international normalized ratio was reached.
Measurements
Arterial blood gases were taken as reference values
once every hour and were analyzed in a blood gas
analyzer (ABL800 FLEX; Radiometer Medical, Copenhagen,
Denmark). The lactate values displayed by the microdialysis
system were then compared with these reference values. The
microdialysis system is calibrated every 8 hours using the ref-
erence arterial blood gas. The calibrated values were not in-
cluded for comparison. All other paired microdialysis–
arterial blood gas values were included for analysis. For the
optimal evaluation of the microdialysis-generated results, the
arterial blood gas values were compared with the microdialy-
sis results obtained after the 5-minute time lag. The moni-
toring period was ceased when the patient was discharged
from the ICU or after 48 hours. However, patients moni-
tored with the TLC had the catheter in place as long as a
central line was necessary and single paired measurements
could be obtained after the 48-hour monitoring period at
random times.
Statistical analysis
Bland-Altman analysis was performed using MedCalc
version 12.7.5 statistical software (MedCalc Software,
Figure 1 Schematic illustration of the intravascular microdialysis system. The microdialysis membrane is placed in the bloodstream and is
continuously perfused with a perfusion fluid, creating a dialysate. Due to the diffusion of small molecules (for example, lactate) over the
microdialysis membrane, the concentration of these molecules in the dialysate will be the same as that in the bloodstream. The dialysate is then
analyzed by a sensor that converts this information to digital signals, resulting in a numerical value and a trend graph of the lactate values on
a monitor.
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paired samples were obtained from each patient. Bland-
Altman analysis displays the bias (mean of differences)
and limits of agreement (bias ± 1.96 SD) of the paired
lactate values. Overall association between microdialysis
and arterial blood gas lactate concentrations was esti-
mated using a regression coefficient, which was calcu-
lated using a random coefficient mixed model in SAS
version 9.3 statistical software (SAS Institute, Cary, NC,
USA). Remaining statistical analyses, including Pearson
correlation coefficients for each patient, were carried out
using IBM SPSS version 22 statistical software (IBM SPSS,
Chicago, IL, USA). If a high lactate level (>3 mmol/L) was
measured, the possible association with a clinical outcome
was investigated.
Results
Data were available for 78 patients. Data were missing
for two patients monitored with the SLC due to catheter
damage that occurred while performing mitral valve sur-
gery in one patient and due to mechanical sensor failure
in the other. Data were available for analysis in all
patients monitored with the TLC. However, monitoringwas ended prematurely in one patient because of cath-
eter dislocation (accidental withdrawal), which was sub-
sequently detected as the microdialysis values were
accompanied by a warning signal due to rapid changes
in blood lactate levels. In three other patients, the moni-
toring was paused because of sensor complications,
which were also detected by the accompanying warning
signal for uncertain values, but could be restarted after
exchange of the sensor. Two patients monitored with
the TLC had shorter follow-up times than expected
because, by accident, monitoring was not conducted
during nighttime. The patient characteristics from the
included 78 patients are shown in Table 1. The mean
follow-up time for all patients was 25.6 hours (range = 1
to 97, median = 22), and a total of 1,601 paired micro-
dialysis–arterial blood gas lactate values were ob-
tained and included for analysis. An average of 20.5
samples from each patient (range = 1 to 43, median =
19) were analyzed. The values for each patient are
provided in Table 2. No consistent systematic drift
between calibrations was observed (see Additional file
1). Furthermore, we did not notice any increasing
calibration drift with longer monitoring time over
Table 1 Patient characteristicsa




Age (years) 69 14
BMI 25.5 5.35
Ejection fraction (%) 50 10
Diabetic status No diabetes 57
Diabetes type 1 2





AVR + CABG 7
MVR 2
MVR + CABG 1
Aortic graft 4











NA + Nitro 29
NA + Nitro + A 1
NA + Nitro +
Milrinone
1








Transfusions Red blood cells 44 2 4
Plasma 16 0 1
aA = Adrenalin, AVR = Aortic valve replacement, BMI = Body mass index,
CABG = Coronary artery bypass grafting, MVR = Mitral valve replacement,
NA = Noradrenalin, Nitro = Nitroglycerin. Information is provided as either
count (number of patients) or median and interquartile range. For
transfusions both the number of patients receiving either plasma or red
blood cell transfusion as well as the median and interquartile range of the
number of transfusions administered are presented.
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After the removal of the microdialysis catheter, no
blood clotting of the microdialysis membrane was ob-
served and no complications caused by the microdial-
ysis catheter were detected.
The mean (±SD) microdialysis lactate value was 1.40 ±
0.72 mmol/L, and the mean arterial blood gas lactatevalue was 1.38 ± 0.68 mmol/L. The regression coefficient
(calculated using a random coefficient model) was 0.98
(P = 0.0001). The Pearson correlation coefficients (r)
for each patient are presented in Table 2 (median =
0.92, range = 0.19 to 1). The mean relative difference
was 1.5%, and the mean absolute relative difference
was 10.3%. The Bland-Altman analysis showed a bias ±
limits of agreement of 0.02 ± 0.42 mmol/L (Figure 2).
An example of a patient’s microdialysis lactate values
compared with arterial blood gas lactate values is
shown in Figure 3.
In 18 patients, a microdialysis lactate value >3.0 mmol/L
was obtained, and the following adverse events occurred
in seven of these patients: reoperation for bleeding (n = 5),
perioperative myocardial infarction (n = 1) and circulatory
instability with transient visceral ischemia (n = 1). If the
cutoff point had been set to 2.5 mmol/L, another patient
who underwent reoperation for bleeding would have been
noted, as would another nine patients for whom no ad-
verse events were recorded. A cutoff point <2.5 mmol/L
would not have added more patients with recorded ad-
verse events.
Discussion
In this study, we demonstrate that intravascular microdi-
alysis may be used for the continuous monitoring of lactate
in patients undergoing cardiac surgery. The microdialysis
lactate values were well correlated and had low bias com-
pared with reference arterial blood gas lactate values.
The system recognized its malfunction in six patients
(as described in Results, first paragraph) and could be cor-
rected for, and the system restarted in three patients.
Overall, the correlation coefficient for each patient showed
good association between microdialysis lactate and arterial
blood gas lactate concentrations. However, a few patients
with low correlation coefficients need to be discussed. The
reason for correlation coefficients <0.5 was one or two
outliers. For example, patient 6, who was monitored
with the TLC, the correlation coefficient would be 0.83
(P = 0.0001) instead of 0.19 if one outlier were removed.
Similarly, removal of one or two outliers in the remaining
patients with correlation coefficients <0.5 would yield new
correlation coefficients >0.75 (all with P < 0.01).
The monitoring of lactate has been made easier with
point-of-care testing. Studies have been conducted to
analyze the differences in arterial, venous and capillary
lactate monitoring methods with findings of high accur-
acy [20]. There are several reasons why we used arterial
samples both as a reference measurement method and for
calibration of the central venous microdialysis measure-
ments. First, arterial samples of lactate (and glucose) may
be considered the standard method, and they are regularly
taken in critically ill patients as opposed to central venous
samples. Differences between central venous and arterial
Table 2 Microdialysis–arterial blood gas lactate paired
samples data per patienta





SLC 1 20 0.98 0.0001
SLC 3 18 0.904 0.0001
SLC 4 15 0.931 0.0001
SLC 5 20 0.948 0.0001
SLC 6 18 0.817 0.0001
SLC 7 16 0.896 0.0001
SLC 8 18 0.94 0.0001
SLC 9 20 0.947 0.0001
SLC 10 39 0.889 0.0001
SLC 11 17 0.952 0.0001
SLC 12 19 0.985 0.0001
SLC 13 9 0.949 0.0001
SLC 14 10 0.954 0.0001
SLC 15 18 0.835 0.0001
SLC 16 17 0.971 0.0001
SLC 17 41 0.959 0.0001
SLC 18 17 0.896 0.0001
SLC 19 35 0.982 0.0001
SLC 20 17 0.401 0.11
SLC 21 39 0.753 0.0001
SLC 22 20 0.681 0.001
SLC 23 39 0.884 0.0001
SLC 24 19 0.738 0.0001
SLC 25 20 0.804 0.0001
SLC 26 21 0.966 0.0001
SLC 27 29 0.95 0.0001
SLC 28 18 0.98 0.0001
SLC 29 20 0.939 0.0001
SLC 30 20 0.93 0.0001
SLC 32 19 0.989 0.0001
SLC 33 9 0.704 0.034
SLC 34 8 0.96 0.0001
SLC 35 17 0.99 0.0001
SLC 36 21 0.978 0.0001
SLC 37 19 0.908 0.0001
SLC 38 38 0.995 0.0001
SLC 39 21 0.935 0.0001
SLC 40 21 0.926 0.0001
SLC 41 19 0.956 0.0001
SLC 42 18 0.875 0.0001
SLC 43 18 0.939 0.0001
SLC 44 21 0.87 0.0001
SLC 45 20 0.949 0.0001
Table 2 Microdialysis–arterial blood gas lactate paired
samples data per patienta (Continued)
SLC 46 16 0.937 0.0001
SLC 47 19 0.939 0.0001
SLC 48 21 0.974 0.0001
SLC 49 20 0.977 0.0001
SLC 50 20 0.88 0.0001
TLC 1 19 0.945 0.0001
TLC 2 34 0.903 0.0001
TLC 3 19 0.846 0.0001
TLC 4 18 0.573 0.013
TLC 5 5 0.811 0.096
TLC 6 19 0.474 0.04
TLC 7 10 0.993 0.0001
TLC 8 20 0.974 0.0001
TLC 9 18 0.886 0.0001
TLC 10 24 0.927 0.0001
TLC 11 20 0.972 0.0001
TLC 12 1 – –
TLC 13 36 0.956 0.0001
TLC 14 20 0.979 0.0001
TLC 15 19 0.971 0.0001
TLC 16 21 0.976 0.0001
TLC 17 22 0.987 0.0001
TLC 18 41 0.929 0.0001
TLC 19 20 0.987 0.0001
TLC 20 43 0.957 0.0001
TLC 21 2 1 0.0001
TLC 22 19 0.19 0.436
TLC 23 21 0.95 0.0001
TLC 24 43 0.985 0.0001
TLC 25 15 0.522 0.046
TLC 26 20 0.781 0.0001
TLC 27 21 0.992 0.0001
TLC 28 10 0.867 0.001
TLC 29 21 0.968 0.0001
TLC 30 6 0.833 0.039
aSLC, Single-lumen catheter; TLC, Triple-lumen catheter.
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al. studied the correlation between central venous and
arterial lactate values and observed a mean difference
of 0.03 mmol/L (r = 0.996) [23]. In our previous study,
we also found good agreement between arterial and ven-
ous blood gas lactate values (mean difference = 0.09 mmol/
L, limit of agreement ±0.6 mmol/L and Pearson correlation
coefficient = 0.92), further supporting arterial blood gas as































Mean Lactate (mmol/L) 
Figure 2 Scatterplot representing Bland-Altman analysis. Mean
microdialysis lactate and reference arterial blood gas lactate values
vs. the difference between the two statistical analysis methods. Bold
line represents bias (mean difference), and dotted lines represent
limits of agreement (±1.96 SD). Art-BG, Arterial blood gas;
MD, Microdialysis.
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performed by assessing the lactate trend by repeated lac-
tate sampling, which may be used for predicting in-
hospital mortality [11]. Jansen and colleagues used a
time interval of 2 hours in their early lactate-guided
therapy study [12]. Continuous monitoring may be ad-
vantageous for the critically ill patient, as the clinician is
provided information every minute that could potentially
be used to support and evaluate the given treatment.
Interestingly, we observed a higher complication rate in
patients with a postoperative lactate level >3 mmol/L. It
should be stressed that the goal of our study was not to
evaluate lactate-guided treatment. The sample size was
not adequate to evaluate the association between lactate



























Figure 3 Example of one patient’s microdialysis and arterial blood ga
blood lactate value of 5.4 mmol/L while experiencing postoperative comp
Art-BG, = Arterial blood gas; MD, Microdialysis.has some value because continuous lactate monitoring
may add further knowledge in this field, which is why we
mention this observation in our results. The hypothetical
cutoff point of >3.0 mmol/L was based on a recent study
in which the researchers reported the association between
high lactate values and postoperative complications in
adult cardiac surgery patients [15]. Investigators in other
studies in which a higher cutoff point (3.0 to 3.5 mmol/L)
was used have reported a better predictive value relating
hyperlactatemia with mortality [2], even though signifi-
cantly increased mortality has previously been observed
with a cutoff point of 1.5 mmol/L [24].
We hypothesize that the continuous monitoring of lac-
tate may aid in lactate-guided treatment in patients who
present with elevated lactate levels, but this remains to
be further studied. Studies on lactate-guided treatment
have been performed early in critical illness (set to the
first 8 hours after ICU admission in the study by Jansen
et al. [12]), and thus it seems to be important to start
lactate monitoring as early as possible. Hence, eligible
patients should receive the TLC with integrated microdi-
alysis function as soon as possible after arrival to the
ICU. This protocol should not constitute a clinical prob-
lem, because these patients usually require rapid central
venous access and thus could just as easily receive the
microdialysis TLC in place of a regular CVC. If a clinical
benefit could be demonstrated with the continuous
monitoring of lactate, the cost-effectiveness of utilizing
TLCs instead of CVCs would need to be calculated as
well.
One should be mindful that this is a pilot study that
needs to be further substantiated. In our present study,
intravascular microdialysis was evaluated for continuous
lactate monitoring in patients undergoing cardiac sur-




s lactate values over time. This patient had a maximal microdialysis
lications with circulatory instability and transient visceral ischemia.
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medical ICU patients would be of value.
Conclusions
We demonstrate that central venous microdialysis is a
robust method for continuous blood lactate monitoring
in patients undergoing cardiac surgery. This system con-
stitutes a novel and interesting new method of monitor-
ing blood lactate concentration and may be useful in
monitoring critically ill patients.
Key messages
 Persistent elevated lactate concentration in critically
ill patients is associated with adverse outcomes.
 Continuous monitoring of lactate may be performed
using intravascular microdialysis.
 Intravascular microdialysis lactate values correlated
well with arterial blood gas reference measurements.
 Continuous lactate monitoring enables lactate-guided
therapy.
Additional files
Additional file 1: Graph depicting lactate calibration drift. No
systematic drift between calibrations could be detected by plotting the
difference in lactate (microdialysis lactate–arterial blood gas lactate (MD–ArtBG))
in millimolar concentrations per liter against time after calibration.
Additional file 2: Scatterplot of lactate differences over monitoring
time. We did not observe an increasing calibration drift with longer
monitoring time over subsequent calibration periods, as shown by
plotting the difference in lactate (microdialysis lactate–arterial blood gas
lactate (MD–ArtBG)) in millimolar concentrations per liter against follow-up
time.
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